Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complement Ther Med 17: 216-223

Author(s): Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, et al.


Objectives:To investigate the usage patterns of complementary and alternative medicines (CAMs), as well as dietary interventions, by South Australian people with multiple sclerosis (MS).

Design:Self-administered postal survey.

Setting:Questionnaire mailed to recipients of the South Australian (SA) MS Society newsletter (n=1230).

Main outcome measures:Patterns of CAMs use and dietary interventions, reasons for using/not using CAMs in MS, sources of CAMs information and monthly expenditure on CAMs/dietary interventions.

Results:A total of 428 surveys were returned (response rate 34.8%) of which 416 met the inclusion criteria for analysis. The majority of SA people with MS who responded reported using CAMs/dietary interventions (64.7%). Respondents with tertiary education and those with mild and moderate disease reported highest CAM use. The most frequently used CAM product categories were vitamins (81.8%), essential fatty acids (80.7%) and minerals (62.5%). Commonly used herbal products included Ginkgo biloba (18.2%) and valerian (16.4%). Popular diets were the low fat (39.8%), low/no sugar (23.8%) and gluten-free (16.4%) diets. The majority of those using CAMs/dietary interventions did so concurrently with conventional treatments (72.1%). Reasons for use included: general health and well-being; to alleviate 'general' as well as specific MS symptoms such as muscle weakness, urinary or memory problems and mobility. Conventional health professionals, and friends/family, were the most common sources of information. Monthly expenditure was most commonly AUD$20-49/month.

Conclusion:This study reports frequent use of CAM/dietary intervention amongst SA people with MS. The majority of users did so in conjunction with conventional treatments.

Similar Articles

Epidemiology and diagnosis of multiple sclerosis

Author(s): Hassan-Smith G, Douglas MR

Multiple sclerosis: current treatment algorithms

Author(s): Río J, Comabella M, Montalban X

Predictors of alternative medicine use by multiple sclerosis patients

Author(s): Marrie RA, Hadjimichael O, Vollmer T

Complementary and alternative medicine for multiple sclerosis

Author(s): Schwarz S, Knorr C, Geiger H, Flachenecker P

A randomized pilot study of naturopathic medicine in multiple sclerosis

Author(s): Shinto L, Calabrese C, Morris C, Yadav V, Griffith D, et al.

Comparative effects of DHA and EPA on cell function

Author(s): Gorjão R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M, et al.

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

Author(s): Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, et al.

Leukotrienes in the cerebrospinal fluid of multiple sclerosis patients

Author(s): Neu I, Mallinger J, Wildfeuer A, Mehlber L

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients

Author(s): Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, et al.